HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Posaconazole for chronic pulmonary aspergillosis: the next strategy against the threat of azole-resistant Aspergillus infection.

AuthorsShigeru Kohno, Koichi Izumikawa
JournalClinical infectious diseases : an official publication of the Infectious Diseases Society of America (Clin Infect Dis) Vol. 51 Issue 12 Pg. 1392-4 (Dec 15 2010) ISSN: 1537-6591 [Electronic] United States
PMID21054178 (Publication Type: Comment, Editorial)
Chemical References
  • Antifungal Agents
  • Triazoles
  • posaconazole
Topics
  • Antifungal Agents (therapeutic use)
  • Aspergillus (drug effects)
  • Drug Resistance, Fungal
  • Humans
  • Pulmonary Aspergillosis (drug therapy)
  • Treatment Outcome
  • Triazoles (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: